<DOC>
	<DOCNO>NCT01861704</DOCNO>
	<brief_summary>Randomized post market study compare Lyric Lyric2 capture information regard comparative performance safety .</brief_summary>
	<brief_title>Post-market Study Capture Information Regarding Performance Lyric2</brief_title>
	<detailed_description>Randomized post market study compare extend wear hearing aid Lyric Lyric2 capture information regard comparative performance safety .</detailed_description>
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<criteria>Aged 1890 year time enrollment study Mild moderatelysevere hear loss bilaterally , unilaterally normal hear ear Fluent English Willingness comply study requirement Scuba dive sky dive Underwater swim dive water Handicaps would restrict participation evaluation Hearing loss neural central origin Unrealistic expectation regard benefit limitation inherent device Chemotherapy within last six month Compromised immune system Radiation head neck Perforated tympanic membrane History cholesteatoma Active outer middle ear pathology High level anticoagulant therapy Insulindependent and/or uncontrolled diabetes Contact dermatitis Bleeding disorder Unwillingness inability comply study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Mild moderate hearing loss</keyword>
</DOC>